Email this article NEPHROPATHIES IN MALIGNANT TUMORS (LECTURE)
- Authors: Kolina I.B.1, Bobkova I.N.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: No 30 (2014)
- Pages: 108-116
- Section: LECTURE
- URL: https://almclinmed.ru/jour/article/view/298
- DOI: https://doi.org/10.18786/2072-0505-2014-30-108-116
- ID: 298
Cite item
Full Text
Abstract
Kidney damage in patients with malignant tumors (connected both with neoplasia and with their treatment) is important manifestation of disease, which demands close attention of doctors. In the lecture, different mechanisms of nephropathies development in patients with malignant tumors are considered; predictively significant or often met variants of nephropathies and modern approaches to prevention and treatment are discussed.
About the authors
I. B. Kolina
I.M. Sechenov First Moscow State Medical University
Author for correspondence.
Email: fake@neicon.ru
Россия
I. N. Bobkova
I.M. Sechenov First Moscow State Medical University
Email: fake@neicon.ru
Россия
References
- Козловская Л.В., Туганбекова С.К., Сейсембеков Т. и др. Паранеопластическое поражение почек при солидных опухолях//Нефрол. и диализ. 2002. №2.
- Кондратьев В.Б. Метастазы в кости: осложненные формы, гиперкальциемия, синдром компрессии спинного мозга, медикаментозное лечение//Практич. онкол. 2000. N92. С.41-45.
- Метелева H.A., Козловская Н.Л., Спесивцев В.H., Глазкова Е.К. Лучевая терапия как причина нарушения функции почек и артериальной гипертензии при опухолях урогенитальной локализации//Нефрол. и диализ 2008. N93-4.
- Мухин H.A., Хасабов H.H., Дзгоева Ф.У. Паранеопластический амилоидоз//Тер. арх. 1986. N94. С.95-98.
- Сомонова О.В. Тромботические осложнения и их профилактика у больных со злокачественными новообразованиями//Урол. сегодня. 2010. N95. С.12-13.
- Bachetta J., Juillard L., Cochat P. et al. Paraneoplastic glomerular diseases and malignancies//Oncology/Hematology. 2009.V.70. P.39-50.
- Banerjee D., Asif A., Striker L. et al. Short-term, high-dose pamidronate-induced acute tubular necrosis: The postulated mechanisms of bisphosphonate nephrotoxicity//Am. J. Kidney Dis. 2003. V.41. P.E18.
- Содап М.G., Arieff A.I. Radiation nephritis and intravascular coagulation//Clin. Nephrol. 1978. V.10, No.2. P.74-78.
- Dimopoulos M.A., Terpos E., Chanan-Khan A. et al. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group//J. Clin. Oncol. 2010. V.28, No,33. P.4976-4984.
- Fried L. et al. Kidney function as predictive of not cardiovascular mortality//J. Am. Soc. Nephrol. 2005. V.16, No.12. P.3728-3725.
- Geerts W.H., Bergqvist D., Pineo G.F. et al. Prevention of venous thromboembolism//Chest. 2008. V.133, No. P.381S-453S.
- Hande K.R., Garrow G.C. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma//Am. J. Med. 1993. V.94. P.133.
- Hsu C.Y. Yes, AKI truly leads to CKD//J. Am. Soc. Nephrol. 2012 V.23. P.967-969.
- Huggia F.M. Overview of cancer related hypercalcemia: epidemiology and etiology//Semin. Oncol. 1990. V.17. P.3-9.
- Manning E.C., ВеIепко М.I., Frauenhoffer E.E., Ahsan N. Acute renal failure secondary to solid tumor renal métastasés: Case report and review of the literature//Am. J. Kidney Dis. 1996. V.27. P.284-291.
- Markowitz G.S., Fine P.L., D'Agati V.D. Nephrotic syndrome after treatment with pamidronate//Am. J. Kidney Dis. 2002. V.39. P.1118-1122.
- Markowitz G.S., Fine P.L., Stack J.L. et al. Toxic acute tubular necrosis following treatment with zoledronate (Zometa)//Kidney Int. 2003. V.64. P.281-289.
- Ronco P.M. Paraneoplastic glomerulopathies: new insights into an old entity//Kidney Int. 1999. V.56. P.355-377.
- Smetana S., Michlin A., Rosenman E. et al. Pamidronate-induced nephrotoxic tubular necrosis-a case report//Clin. Nephrol. 2004. V.61. P.63-67.
- Yeong-Hau H. et al. Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis//Nat. Rev. Nephrol. 2011. V.7, No.2. P.85-95.
Supplementary files
